EyePoint Pharmaceuticals

EYPT

NASDAQHealth Care

Income Statement

Total Revenue$43.27M

Gross Profit$39.56M

Operating Income$-145.85M

EBITDA$-129.23M

EBIT$-130.77M

Pre-tax Income$-231.68M

Net Income$-130.87M

Cash Equivalent$135.48M

Total Debt$17.64M

Book Value$258.37M

Book Value Per Share4.62

Return on Equity (ROE)-38.89%

Return on Assets (ROA)-31.27%

Return on Invested Capital (ROI)-38.89%

Net Profit Margin-302.43%

Current Ratio7.81

Quick Ratio7.57

Long-Term Debt / Equity0.00